Acumen Pharmaceuticals
Executivos
Veja o organograma con seus 32 executivos principais
Biografias mais buscadas da Acumen Pharmaceuticals
- Daniel O'Connell, President & Chief Executive Officer
- Nathan Fountain, Director
- Sean Stalfort, Chairman of the Board
Recentes movimentos de executivos em Acumen Pharmaceuticals
- James Doherty, ingressou na Companhia como President and Chief Development Officer (Notícia publicada em 2 de fevereiro de 2024).
Criar um alerta
para seguir os movimentos de executivos da Acumen Pharmaceuticals.
Farmacêutica
Acumen Pharmaceuticals possui 1.860 concorrentes concorrentes Pfizer (Estados Unidos), Sanofi (França) e Johnson & Johnson (Estados Unidos).
Popular M&A news in Farmacêutica
- MedMen has filed for bankruptcy protection (publicado em 28 de abril de 2024).
- AstraZeneca has announced the acquisition of Fusion Pharma (publicado em 23 de março de 2024).
- AstraZeneca has announced the acquisition of Amolyt Pharma (publicado em 19 de março de 2024).
Outros contatos sugeridos na indústria do Farmacêutica
Notícias
Últimos comunicados de imprensa de Acumen Pharmaceuticals
- X4 Pharmaceuticals to Participate in Upcoming November Investor Conferences | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Reports Third-Quarter 2023 Financial Results and Provides Corporate Updates | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals to Report Third-Quarter 2023 Financial Results and Host a Conference Call and Webcast on November 9, 2023 | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Announces FDA Acceptance with Priority Review of U.S. NDA for Mavorixafor in WHIM Syndrome | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Announces Appointment of Industry Veteran R. Keith Woods to Board of Directors | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Announces Submission of New Drug Application (NDA) to U.S. FDA for Mavorixafor in WHIM Syndrome | X4 Pharmaceuticals, Inc.
- News Releases | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | X4 Pharmaceuticals, Inc.
- X4 Pharmaceuticals to Participate in the Cantor Global Healthcare Conference | X4 Pharmaceuticals, Inc.
- View more press releases Close
Redes sociais sobre Acumen Pharmaceuticals
- Acumen Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
- Acumen Pharmaceuticals na LinkedIn, Twitter e YouTube
Entrar em contato
Contate seus executivos por e-mail agora, incluindo Daniel O'Connell 
Ligue para a Acumen Pharmaceuticals em +1 650...
